JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Margolis, R. U.
Right arrow Articles by Heller, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Margolis, R. U.
Right arrow Articles by Heller, A.
Journal of Pharmacology And Experimental Therapeutics, Vol. 151, Issue 2, 307-312, 1966
Copyright © 1966 by American Society for Pharmacology and Experimental Therapeutics


THE EFFECT OF CHOLINERGIC AND OTHER PHARMACOLOGIC AGENTS ON BRAIN MONOPHOSPHOINOSITIDE TURNOVER IN VIVO

Richard U. Margolis 1 and Alfred Heller 1

1 Department of Pharmacology, University of Chicago, Chicago, Illinois

The effect of various parasympathomimetic and other drugs on brain monophosphoinositide turnover was studied in vivo. Parathion increased brain acetylcholine levels by 95% and produced a concomitant increase of 29% in brain monophosphoinositide turnover. Pilocarpine in doses of 2 mg/kg or greater increased monophosphoinositide turnover by 38%. This effect of pilocarpine was abolished by pretreatment with the atropine, which by itself had no effect on monophosphoinositide turnover. Amphetamine did not increase monophophoinositide turnover, and peripheral cholinergic stimulation produced by bethanechol was also without effect. Pentobarbital was found to decrease monophosphoinositide turnover by 21% in the presence of a 28% increase in brain acetylcholine levels. These results demonstrate that central cholinergic stimulation in rats is accompanied by an increase in brain monophosphoinositide turnover in vivo. This effect appears to be of a specifically cholinergic nature.

Accepted on August 18, 1965







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1966 by the American Society for Pharmacology and Experimental Therapeutics.